Roadmap for ending TB in China by 2035: The challenges and strategies

Qishun Feng; Guoliang Zhang; Liang Chen; Huizhong Wu; Yingzhou Yang; Qian Gao; Tetsuya Asakawa; Yanlin Zhao; Shuihua Lu; Lin Zhou; Hongzhou Lu

doi:10.5582/bst.2023.01325

Review

Roadmap for ending TB in China by 2035: The challenges and strategies

Qishun Feng, Guoliang Zhang, Liang Chen, Huizhong Wu, Yingzhou Yang, Qian Gao, Tetsuya Asakawa, Yanlin Zhao, Shuihua Lu, Lin Zhou, Hongzhou Lu

著者情報

Qishun Feng
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Guoliang Zhang
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Liang Chen
Guangdong Provincial Research Center for Public Health, Guangdong Provincial Center for Diseases Control and Prevention, Guangzhou, Guangdong, China.
Huizhong Wu
Guangdong Provincial Center for Tuberculosis Control, Guangzhou, Guangdong, China.
Yingzhou Yang
Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Qian Gao
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, China.
Tetsuya Asakawa
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yanlin Zhao
National Tuberculosis Reference Laboratory, Chinese Center for Disease Control and Prevention, Beijing, China.
Shuihua Lu
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Lin Zhou
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China.
Hongzhou Lu
National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.

キーワード: tuberculosis, end TB, challenges, strategies

ジャーナルフリー

2024 年 18 巻 1 号 p. 11-20

DOI https://doi.org/10.5582/bst.2023.01325

Browse “Advance online publication” version

詳細

抄録

Tuberculosis (TB) is one of the top ten causes of death worldwide, taking the lives of over a million people annually. In addition to being a serious health issue, TB is also closely linked to eradicating poverty according to the Sustainable Development Goals (SDGs) of the United Nations (UN). All UN members have committed to ending the TB epidemic by 2030. China has one of the highest TB loads worldwide, ranking third in the world on many TB burden indices. The national strategy for TB control is aimed at creating a collaborative network and integrating TB treatment into the medical system. According to the WHO's global TB report, China is expected to have 748,000 new cases of TB in 2022 and an incidence of 52 cases per 100,000 people. Ending TB remains a huge challenge and requires comprehensive control strategies in China. In this work, we have discussed the challenges of TB prevention and control in China and proposed specific measures to end TB.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）